975309

Gilead Sciences, Inc. — FEI 1000523075

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
May 11, 2016
Fiscal Year
2016
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Foster City, CA (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)